We introduce CAN-Scan, a precision oncology platform, which applies ML on next-generation pharmacogenomic datasets generated from a freeze-viable biobank of patient-derived primary cell lines (PDCs).
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00126-0



